chronic glutamine supplementation increases nasal but not salivary iga during nine days of interval...
TRANSCRIPT
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
1/31
CHRONIC GLUTAMINE SUPPLEMENTATION INCREASES NASAL BUT NOT
SALIVARY IgA DURING NINE DAYS OF INTERVAL TRAINING
Krieger, James W.1, Crowe, Michelle1, and Blank, Sally E.1
1Clinical and Experimental Exercise Science Graduate Program, Washington State
University Spokane, Spokane, WA, 99202-1495
Running Head: CHRONIC GLUTAMINE SUPPLEMENTATION AND NASAL IgA
Contact Information:
James Krieger
Department of Food Science and Human Nutrition
University of Florida
P.O. Box 110370
359 FSHN Building
Newell Drive
Gainesville, FL 32611-0370
Phone: (352) 359-1236
Fax: (352) 392-9467
Articles in PresS. J Appl Physiol (April 23, 2004). 10.1152/japplphysiol.00971.2003
Copyright 2004 by the American Physiological Society.
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
2/31
1
ABSTRACT
Oral glutamine supplementation during and after exercise abolishes exercise-induced
decreases in plasma glutamine concentration but does not affect secretory IgA (sIgA)
salivary output. Whether chronic glutamine supplementation during high intensity interval
training influences salivary and nasal sIgA concentration is unknown. PURPOSE: To
examine the effects of chronic glutamine supplementation on sIgA during intense running
training. METHODS: Runners (n= 13, body mass 69.9 2.8 kg, VO2 peak 55.5 2
mL.kg-1min-1, age 29.1 2.8 yr.) participated in twice-daily interval training for 9-9.5 days,
followed by recovery (5-7 days). Oral glutamine supplement (0.1 g
.
kg
-1
) or placebo was
given four times daily for the first 14 days. After an overnight fast, venous blood, nasal
washes, and stimulated saliva were collected at baseline (T1), mid-training (T2), post
training (T3), and after recovery (T4). Mood states were assessed using Profile of Mood
States (POMS) inventories. RESULTS: Glutamine concentration in resting subjects
decreased from T1 to T4 (p
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
3/31
2
INTRODUCTION
Epidemiological and anecdotal evidence suggest that athletes engaged in high
volume and/or high intensity training are at an increased risk for upper respiratory tract
infections (URTI) compared to athletes engaged in more moderate forms of training (21).
The mechanisms behind these clinical manifestations are not clear but may result from
training-related changes in immune indices including decreased salivary IgA concentration
and secretion rates (12, 22-24, 35, 36).
Newsholme (29) proposed that decreased availability of glutamine to immune cells
may be a key factor behind some of the changes in an athletes immune system. Glutamine
is an important fuel for immune cells and intestinal mucosal cells (38). Lymphocytes and
macrophages utilize glutamine at high rates and are dependent upon glutamine for
replication (29). Clinical evidence also exists for improved immune indices and reduced
infection rates when glutamine supplementation is provided to trauma, cancer, and post-
operative patients with low plasma glutamine concentration (8). Although physical
training does not typically predispose athletes to extensive periods of reduced plasma
glutamine concentration as observed in clinical populations, Newsholme (29) postulated
that when plasma glutamine concentration decreases below a physiologically normal range
of 0.5-0.9 mM (3), limited glutamine availability may impair certain immune cell
functions, and, in turn, increase an individuals susceptibility to infections, such as URTI.
Plasma glutamine concentration can decrease in response to chronic, intense
interval training (17), and as a result of overtraining (18, 25, 31, 33). Plasma
concentrations of less than 0.5 mM have been observed in resting athletes during intense
training (17, 18). Furthermore, increased incidence of infection was observed in athletes
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
4/31
3
with decreased plasma glutamine concentration (18), although this outcome is not
consistently reported (25). Controversial evidence exists for the efficacy of glutamine
supplementation on immune indices and infection incidence in athletes engaged in intense
exercise. In two literature reviews of glutamine supplementation, exercise, and immune
indices, it was concluded that changes in plasma glutamine concentration most likely do
not play a role in changes in immune indices, including salivary IgA concentration, and
that glutamine supplementation would not beneficial to athletes (16, 30). However, it
should be noted that all research to date has only involved acute supplementation during
and after a single bout of exercise.
The effect of chronic, high-dose glutamine supplementation on the immune system
of human athletes during overload training has not been investigated. Unlike acute
exercise, which may only marginally affect glutamine homeostasis for a short period of
time, repetitive and intense training may repeatedly challenge glutamine homeostasis and
adversely affect certain immune cell functions (29). Intense exercise may induce small
transient decrements in plasma glutamine concentration, which are manifested by a greater
decline in glutamine availability to mucosal tissues (29). Repetitive reductions in
glutamine supply to IgA-producing lymphoid cells could affect their ability to produce IgA
and increase susceptibility to infection. Under such conditions, chronic glutamine
supplementation would, theoretically, help maintain glutamine homeostasis and sIgA
concentration. No studies, to date, have attempted to utilize chronic glutamine
supplementation to prevent the decrease in secretory IgA associated with intense training.
In addition, only the effects of intense exercise on salivary IgA have been reported in the
literature. However, some pathogens, such as rhinovirus, only infect nasal mucosa (14).
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
5/31
4
Thus, investigation of the effects of supplementation and intense training on nasal IgA is
warranted.
The purpose of this study was to determine whether chronic, high-dose glutamine
supplementation would affect salivary and nasal IgA during a nine-day, intense interval
training program. We hypothesized that supplementation would attenuate training-induced
decreases in plasma glutamine and sIgA concentrations.
METHODS
Subject recruitment and cohorts
Thirteen healthy runners (four females and nine males) were recruited by
advertisement within the local community. Inclusion criteria required subjects to: 1) be
between the ages of 18 and 49 years; 2) currently run a minimum of 20 miles per week, and
3) have a peak whole body oxygen uptake (VO2 peak) of at least 52.5 ml.kg
-1min
-1for males
or 41.0 ml.kg-1min-1 for females. These values are classified as superior according to
Coopers aerobic fitness classifications (5). Exclusion criteria included: self-reported
respiratory illness within seven days prior to training, prescription/non-prescription drug
use, smoking, obesity, use of dietary supplements other than a multivitamin, illegal drug
use, food/caffeine intake less than eight hours prior to testing, alcohol intake less than eight
hours prior to testing, injury which impedes training, illness, diabetes, pregnancy, any
heart, respiratory, or liver condition that contraindicated intense exercise training, and any
other health condition that contraindicated intense exercise training. Washington State
Universitys Institutional Review Board approved the study and written consent was
obtained before data collection. Subjects were compensated $100 upon successful
completion of the study. The subjects were randomly assigned to receive glutamine (G, n =
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
6/31
5
6) or placebo (P, n = 7). A male subject from the placebo group withdrew after the second
testing day due to self-diagnosed URTI. Because this subject completed two testing days,
his data were included in the final analysis.
Testing and Training
During the week prior to the commencement of the study, subjects were given an
orientation to the testing and training procedures. Testing was conducted at the Exercise
Science Human Physiology Laboratories at Washington State University. Subjects were
tested for body mass, body composition, and peak oxygen uptake during treadmill running.
The treadmill protocol was performed according to a modification of a protocol described
by Fry et al. (10). Briefly, subjects walked or ran on the treadmill at a self-selected speed
and grade as a warm-up for a self-selected period. Subjects then ran for four min at 12
km.h
-1and a 1% incline. After a three min rest, subjects ran for four min at 15 km
.h
-1and a
1% incline. After another three min rest, subjects ran to volitional exhaustion at 18 km.h-1
and a 1% incline. Whole body oxygen uptake was measured using an open circuitry, on-
line gas analysis system (Sensormedics, Loma Linda, CA). Body mass was determined by
a standard laboratory scale. Bioelectrical impedance (Omron, Vernon Hills, IL) was used
to assess subject body composition. Heart rate was monitored every 30 s telemetrically
(Polar, Woodbury, NY).
Training took place on outdoor or indoor tracks according to a modification of
protocol of Fry et al. (10). Subjects participated in 9-9 days of twice a day interval
training, beginning on day 1, the day of initial testing. Subjects performed a warm-up at a
self-selected pace for a self-selected time. Morning sessions were conducted between 6 - 9
AM and included 15 x 1 min runs performed separated by two min recovery, where
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
7/31
6
subjects were permitted to walk briskly. Afternoon sessions were conducted between 4-8
PM and involved 10 x 1 min run periods separated by one min recovery. Subjects ran at a
pace approximate to the speed of the final stage that they reached during the preliminary
treadmill test. If subjects were not able to maintain the required pace, the distance was
reduced by 25 m until the subject was able to maintain pace. Heart rates were monitored
telemetrically via Polar Vantage XL heart rate monitors. All training sessions were
supervised. A 96% compliance rate was obtained. Reasons for absences from training
included: participation in races on the day of training and complaints of muscle pain from
training. The training period was followed by a 5-day recovery period where subjects
returned to their normal daily exercise or physical activities.
Subject Testing
Testing was performed on day 1 (T1), days 6-7 (T2), day 11 (T3), and day 16 or
day 18 (T4). Subjects arrived at the lab between 6-8 AM after an overnight fast. Subjects
were requested to not brush their teeth before they came to the lab, and to have not
consumed food or beverage (with the exception of water), or exercise for at least eight
hours prior. Subjects provided blood, nasal wash, and stimulated saliva samples, and each
subject filled out a Profile of Mood States (POMS) questionnaire (26). Total mood
disturbance, a composite mood assessment, was determined according to Morgan et al.
(27). At T4, two of the subjects failed to comply with the no-exercise requirement prior to
testing. Samples were collected from these subjects approximately three hours post-
exercise. The values for these subjects were not greater than one standard deviation from
the mean of the group, and therefore, their data were included in the analysis.
Blood
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
8/31
7
The blood samples (~ 15 mL) were obtained via venipuncture of an antecubital
vein. The blood was collected into heparinized vaccutainers. Hematocrit was measured by
microcentrifugation. Hemoglobin concentration was determined using the
cyanmethemoglobin technique. Plasma volume changes were estimated according to Dill
and Costill (7).
Diet
Three-day dietary food records were obtained for days 1-3 or 3-5 and for days 12-
14. Diets were analyzed for average daily caloric, protein, carbohydrate, and fat content
using Diet Analysis Plus (ESHA Research, Salem, OR).
Supplementation
Subjects received 0.1 g.kg-1 of L-glutamine (Experimental and Applied Sciences,
Golden, CO) mixed with sugar-free Lemonade (Safeway, Inc., Pleasanton, CA) or a
placebo (sugar-free lemonade only) four times daily for 14 days beginning on the first day
of training. Subjects were blinded to which treatment they received. The
supplement/placebo was mixed in approximately 300 mL of water. Supplement and
placebo were identical in appearance and taste when mixed. Subjects consumed the drinks
immediately after preparation. Subjects were instructed to consume no protein for 30 min
to avoid competition of other amino acids. During the training period, the first dose was
provided immediately after the morning session. The next dose was provided midway
between the morning and afternoon session. The third dose was provided immediately
after the afternoon session. The last dose was provided in the evening. During the
recovery period, subjects were given their supplement packets ahead of time with
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
9/31
8
instructions on how to prepare the drink. They were also given a sheet on which to record
the times when they consumed the supplement. A 99.7% compliance rate was achieved.
Plasma Glutamine and Total Protein Determination
Plasma samples deproteinized with ice cold 10% perchloric acid and neutralized
with KOH were analyzed for glutamine by enzymatic determination according to the
manufacturers instructions (Sigma Aldrich, St.Louis, MO). The detection range for this
assay is 0.14 - 1.4 mM L-glutamine. Salivary and nasal total protein was analyzed
spectrophotometrically according to Bradford (1). The technicians performing all the
biological assays were blinded to the treatments that the subjects received.
Saliva Collection
Saliva flow was stimulated by chewing a single parafilm (5 cm2) section for a one
min, which typically elicits 1-3 mL..min
-1of flow (6). Subjects were encouraged to allow
the saliva to accumulate in the mouth until the urge to swallow occurred. Without
expectorating, the subjects allowed the saliva to flow into the collection tube and repeated
the entire process until time elapsed. The sample was immediately placed on ice and then
centrifuged to remove cellular debris. The supernatant fluid was frozen at -80 C for later
analysis of IgA and protein concentration.
Nasal Wash
Nasal washes were collected as follows. The subjects head was tilted back at an
angle of approximately 70 from vertical. While the subject closed his/her glottis, a rubber
bulb syringe containing approximately seven mL of sterile phosphate-buffered saline (PBS)
was inserted into a nostril. The subject then tilted his/her head forward to allow the wash
to drip into a sterile cup. The wash sample was immediately placed on ice and then
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
10/31
9
centrifuged to remove cellular debris. The supernatant fluid was frozen at -80 C for later
analysis of IgA and protein concentration.
IgA
Nasal wash and saliva samples were analyzed for IgA concentrations using an
enzyme linked immunosorbent assay. Briefly, 96-well polystyrene plates were coated with
goat antihuman IgA (alpha chain specific, Sigma) diluted in 0.05M carbonate buffer and
incubated overnight at 4C. The residual fluid was gently removed and 1% bovine serum
albumin in PBS added to the wells as a blocking agent. The plate was incubated for one
hour at 37C. After gently removing the fluid, human IgA standards (Sigma), saliva and
nasal samples (diluted 1:500) were added to the wells. The plate was incubated for one
hour at 37C and then washed with PBS/Tween. After gently removing residual fluid,
peroxidase conjugate anti-human IgA (Sigma) was added to each well and the plate
incubated for one hour at 37C. The plate was washed and the fluid gently removed. The
substrate, O-Phenylenediamine in 0.05M phosphate-citrate buffer and 0.03% H202, was
added prior to a 30-min incubation at 37C. The reaction was stopped with 2.5 M HCL
and absorbance read at 490nm (Molecular Devices Corporation, Sunnyvale, CA).
Statistics
Subject demographic data between groups, cohorts, and gender were compared
using an independent t-test. In cases of unequal variances, an Aspin-Welch unequal
variance t-test was used. All other data were modeled using a linear mixed model
estimated by a restricted maximum likelihood (REML) algorithm. Treatment was included
as the between-subject factor, time was included as the repeated within-subjects factor, and
time by treatment was included as the interaction. For heart rate data, training session was
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
11/31
10
also included as repeated within-subjects factor, with all possible interactions among time,
treatment, and session included in the model. Repeated covariance structures were
specified as unstructured, compound symmetry, first-order autoregressive, or toeplitz,
depending on which structure resulted in the best model fit as determined by Hurvich and
Tsais Criterion (AICC). For salivary, nasal, glutamine, and POMS data, baseline values
were included in the model as a covariate. If the covariate was not significant, it was
removed from the model. Due to low sample size and statistical power, gender was not
included as a factor in any mixed model analyses. The normality-of-residuals assumption
required by the REML algorithm was checked using a one-sample Kolmogorov-Smirnov
test on the residuals and via visual inspection of a histogram of the residuals. All data
satisfied the normality-of-residuals assumption.
If significant interactions were present,post-hoc analyses on simple main effects
within each factor level were done using multiple t-tests with a Sidak adjustment. If no
significant interactions existed,post-hoc analyses on main effects were done using multiple
t-tests with a Sidak adjustment. Main effects for salivary IgA, salivary IgA:protein,
salivary IgA output, nasal IgA:protein, and plasma glutamine, were declared significant at a
one-tailed critical alpha of .05. All interactions, and all other main effects, were tested
using the null hypothesis and were declared significant at a two-tailed alpha of .05.
Spearman-rank correlations were determined between plasma glutamine and IgA measures,
plasma glutamine and POMS variables, POMS variables and IgA measures, nasal
IgA/protein and salivary IgA output, and plasma glutamine and dietary protein intake.
Separate correlations were performed for variables where a significant effect of treatment
existed for the placebo group and glutamine group. Otherwise, correlations were
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
12/31
11
conducted using data from all subjects. All analyses were performed using NCSS 2000
(Kaysville, UT) and SPSS 12.0 (Chicago, IL). All data are reported as means standard
error of the mean (SEM).
RESULTS
Physical and physiological characteristics
Subject physical and physiological characteristics were as follows: Males: n = 9,
body mass 73.52.9 kg, VO2 peak 57.82.3 ml/kg/min, age 29.33.8 yr; Females: n = 4,
body mass 61.63.8 kg, VO2 peak 50.32.6 ml/kg/min, age 28.54.4 yr. There were no
significant treatment or group differences in body mass, height, VO2 peak, age, body fat
percentage, lean body mass, or fat mass. Height, body mass, and lean body mass were
significantly higher in males than females (P < .05). There were no significant gender
differences for any other variable. There was no significant effect of treatment on changes
in plasma volume (P = .08). There was a significant effect of time (P = .001). The percent
change in plasma volume from baseline at T4 (3.6% 1.6) was significantly less than at T2
(13.6% 2.9; P = .048) and T3 (18.4% 4.3; P = .001).
Training Heart Rate
There was no significant difference between G and P groups in HR, expressed as a
percentage of age-predicted MHR, at each training session (89.7% 0.4 and 89.3% 0.5 for
P and G groups, respectively, P = .80). HR in the afternoon/evening sessions was higher
than the heart rates in the morning sessions (90.3% 0.4 and 88.7% 0.4, respectively; P =
0.0), and HR steadily decreased from 92.8% 0.6 on the first full day of training to 87.6%
1.2 on the last day of training.
Plasma Glutamine Concentration and Diet
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
13/31
12
There was no significant effect of treatment (P = .14) on plasma glutamine
concentration (Figure 1). There was a significant effect of time (P = .043; Figure 1). Post-
hoc analysis did not reveal any significant differences among days. The training and
glutamine supplementation protocols did not significantly change caloric intake (P = .21
and P = .62, respectively; Table 1), protein intake (P = .60 and P = .16, respectively; Table
1), carbohydrate intake (P = .32 and P = .95, respectively; Table 1), or fat intake (P = .47
and P = .51, respectively; Table 1).
Salivary and Nasal IgA
The treatment and training protocols did not significantly alter salivary flow rate (P
= .67 and P = .47, respectively; Figure 2), salivary IgA concentration (P = .41 and P = .10,
respectively; Figure 3A), salivary IgA output (P = .17 and P = .48, respectively; Figure
3C), and salivary protein concentration (P = .53 and P = .23, respectively; Figure 4). There
was a significant time by treatment interaction for salivary IgA relative to total salivary
protein (P = .021; Figure 3B). Post-hoc analysis revealed that in the placebo group,
salivary IgA/protein was signicantly greater at T2 compared to T1 (P = 0.022; Figure 3B)
and T3 (P = .044; Figure 3B). Salivary IgA/protein was also significantly greater at T2 in
P as compared to G (P = .011; Figure 3B). There was no significant effect of time on nasal
IgA relative to protein (P = .48, Figure 5). There was a significant treatment effect on nasal
IgA per protein content, with the overall mean lower in the P group (264.7 35.0 g/mg
vs. 172.4 33.7 g/mg, P=.047; Figure 5).
POMS
Measures of vigor, fatigue, and composite mood were significantly changed during
the training protocol (Table 2). Post-hoc analysis revealed that vigor was significantly
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
14/31
13
reduced at T3 compared to T1 (P = .024). Fatigue was significantly increased at T2
compared to T1 (P = .013) and T4 (P = .014). Total mood disturbance was significantly
increased at T2 (P = .003) and T3 (P = .01) compared to T4. Measures of anger,
depression, confusion, and tension were not significantly altered by treatment or time
(Table 2).
Correlational Analyses
Statistically weak associations were observed between IgA measures and POMS
indices indicating that POMS scores could not be used as markers of changes in secretory
IgA with training. A significant correlation was observed for salivary flow rate and vigor
(P = .01, r = 0.34)
DISCUSSION
Plasma glutamine concentration decreased significantly with training, which is
consistent with Keast et al. (17) who reported a significant decrease in plasma glutamine
concentration in five military recruits during a 9 day, twice-per-day interval training
protocol. The mechanisms behind the reduction in plasma glutamine concentration in
response to overload training are not currently known but may include renal uptake of
glutamine to maintain acid-base balance under conditions of exercise-induced acidosis
(34).
Plasma glutamine concentration was highly variable with a range of 0.18 0.80
mM and independent of glutamine supplementation. The variability did not reflect
differences in training intensity, because some subjects with low plasma glutamine
concentrations had the lowest % MHR during exercise. It is also unlikely that diet directly
influenced glutamine concentration because protein intake did not change over the course
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
15/31
14
of the study. The diets were however, self-reported and precise determination of protein
intake was not possible.
Glutamine supplementation four times per day would be expected to increase the
average daily concentration of plasma glutamine. An oral dosage of 0.1 g.kg
-1increases
plasma glutamine concentration by 50% within 30 min after administration and glutamine
concentration returns to baseline within 90-120 min (40). The lack of a significant effect of
supplementation in this study can be attributed to the time span of least eight hours between
the last daily glutamine dose and the early morning blood draw in fasted subjects.
Nasal IgA concentration relative to total protein was significantly increased by
chronic glutamine supplementation during training. Covariate analyses indicated that this
effect was independent of baseline group differences. It is not clear why chronic glutamine
supplementation would selectively increase nasal IgA concentration but have no effect on
salivary IgA content. Differences may be due to collection of unstimulated nasal fluid
samples versus stimulated salivary samples. Stimulation by chewing increases epithelial
cell transcytosis of IgA into salivary fluid (32) and may have masked the effects of chronic
glutamine supplementation on basal IgA secretion in non stimulated samples.
To our knowledge, we are the first to report an effect of glutamine supplementation
on nasal IgA during training. It is possible, due to the low power of the test that this effect
occurred by random chance. However, this result seems unlikely given that 83% of the
subjects receiving chronic glutamine supplementation demonstrated an increase in nasal
IgA per protein between T1 and T3 whereas, 63% of the placebo group had a decrease in
this variable during the same period. Increasing the sample size would increase the power
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
16/31
15
of the test. Due to the large variability in nasal IgA concentration, a sample size of at least
32 subjects per group would be required to attain a statistical power of at least 0.80.
Investigation of nasal IgA in athletic populations at increased risk for URTI is
warranted because some viruses that cause URTI, such as rhinovirus, only infect nasal
mucosa (14). The relationship between nasal IgA and infection risk is not as well studied.
Intranasal treatment with nasal IgA reduced the risk of respiratory syncytial virus in rhesus
monkeys (39). Lindberg and Berglund (20) observed that intranasal treatment with IgA did
not reduce risk of URTI symptoms in world-class canoeists over a 17-day period. There
are no studies to date, which include direct evaluation of the relationship between
endogenous nasal IgA and URTI risk.
Supplementation had no effect on salivary IgA concentration or salivary IgA
output. These findings are consistent with Krzywkowski et al. (19), who reported that
glutamine supplementation provided during and after an acute bout of cycle ergometer
exercise failed to prevent the post-exercise decrease in salivary IgA. The results of the
present investigation conflict with other studies in which decreases in salivary IgA
concentration have been observed (2, 13, 21, 35). The disparity may relate to the duration
of the training period used in protocols. The present study included a training period of
approximately nine days, which may not have provided a sufficient stimulus to reduce
early morning salivary IgA in resting subjects. Others have observed decreases in salivary
IgA concentration following longer training periods. Gleeson et al. (13) observed that pre-
exercise salivary IgA concentration in elite swimmers decreased by 4.1% per month during
seven months of training. Tharp and Barnes (35) reported that salivary IgA concentration
in elite swimmers were significantly lower during one month of heavy training versus one
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
17/31
16
month of light or moderate training. Others have reported decreases in sIgA (2) and
salivary IgA/protein ratio (21) after approximately three weeks of strenuous training.
Salivary IgA:protein ratio increased at T2 in the placebo group and was greater at
this time than values observed for the supplemented group. This can be attributed to the
non-significant increase in salivary IgA at T2 in P (P = .054; Figure 3A), with a
concomitant lack of change in salivary protein (Figure 4). The increase in salivary IgA
concentration at T2 in P is most likely due to a reduced salivary flow rate, which also
occurred at this time (Figure 2).
Overload and overtraining are associated with mood disturbances (9, 10, 15, 27)
and reduced secretory IgA concentrations and secretion rates (4, 11, 28). In the present
study, vigor decreased and fatigue increased with interval training and returned to baseline
after the recovery period. These observations are in agreement with the findings of others
(15, 27, 37). Overall, correlational analyses failed to identify POMS scores as indicators of
changes in sIgA during training.
In conclusion, chronic, high-dose glutamine supplementation during nine days of
interval training had no effect on salivary IgA concentration or output or plasma glutamine
concentration in resting athletes. However, supplementation resulted in higher nasal IgA
during training. The biological significance of this effect on nasal IgA (i.e., whether it
helps reduce an athletes risk of URTI during intense periods of training) remains to be
demonstrated.
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
18/31
17
ACKNOWLEDGEMENTS
We thank our subjects for participating in this study and Dr. Kathe Gabel, Dr. Phil
Mixter, Dr. Jackie Banasik, Sara Minier, Jennifer Wilberding, and Jessica Moore for their
technical assistance. This study was financed by a grant from Experimental and Applied
Sciences (EAS), Golden, Colorado, and Washington State University Spokane.
Current address for primary author:
James Krieger
Department of Food Science and Human Nutrition
University of Florida
P.O. Box 110370
359 FSHN Building
Newell Drive
Gainesville, FL 32611-0370
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
19/31
18
REFERENCES
1. Bradford M. A rapid and sensitive method for the quantitation of microgram
quantities of protein utilizing the principle of protein-dye binding.Anal Biochem 72: 248-
254, 1976.
2. Brenner IKM, Severs YD, Rhind SG, Shephard RJ, and Shek PN. Immune
function and incidence of infection during basic infantry training.Mil Med165: 878-883,
2000.
3. Bulus N, Cersosimo E, Ghishan F, and Abumrad NN. Physiologic importance
of glutamine.Metabolism 38: 1-5, 1989.
4. Carins J and Booth C. Salivary immunoglobulin-A as a marker of stress during
strenuous physical training.Aviat Space Environ Med73: 1203-1207, 2002.
5. Cooper KH. The Aerobics Way. New York: Bantam Books, Inc., 1977.
6. Dawes C and Macpherson LM. Effects of nine different chewing-gums and
lozenges on salivary flow rate and pH. Caries Res 26: 176-182, 1992.
7. Dill DB and Costill DL. Calculations of percentage changes in volumes of blood,
plasma, and red blood cells with dehydration.J Appl Physiol 37: 247-248, 1974.
8. Field CJ, Johnson I, and Pratt VC. Glutamine and arginine: immunonutrients
for improved health.Med Sci Sports Exerc 32: S377-S388, 2000.
9. Fry RW, Grove JR, Morton AR, Zeroni PM, Gaudieri S, and Keast D.
Psychological and immunological correlates of acute overtraining.Br J Sports Med28:
241-246, 1994.
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
20/31
19
10. Fry RW, Morton AR, Garcia-Webb P, Crawford GPM, and Keast D.
Biological responses to overload training in endurance sports.Eur J Appl Physiol 64:
335-344, 1992.
11. Gleeson M. Mucosal immune responses and risk of respiratory illness in elite
athletes.Exerc Immunol Rev 6: 5-42, 2000.
12. Gleeson M, Hall ST, McDonald WA, Flanagan AJ, and Clancy RL. Salivary
IgA subclasses and infection risk in elite swimmers.Immunol Cell Biol 77: 351-355,
1999.
13. Gleeson M, McDonald WA, Pyne DB, Cripps AW, Francis JL, Fricker PA,
and Clancy RL. Salivary IgA levels and infection risk in elite swimmers.Med Sci Sports
Exerc 31: 67-73, 1999.
14. Gwaltney JM, Jr. Rhinovirus infection of the normal human airway.Am J Respir
Crit Care Med152: S36-S39, 1995.
15. Halson SL, Lancaster GI, Jeukendrup AE, and Gleeson M. Immunological
responses to overreaching in cyclists.Med Sci Sports Exerc 35: 854-861, 2003.
16. Hiscock N and Pedersen BK. Exercise-induced immunodepression- plasma
glutamine is not the link.J Appl Physiol 93: 813-822, 2002.
17. Keast D, Arstein D, Harper W, Fry RW, and Morton AR. Depression of
plasma glutamine concentration after exercise stress and its possible influence on the
immune system.Med J Aust162: 15-18, 1995.
18. Kingsbury KJ, Kay L, and Hjelm M. Contrasting plasma free amino acid
patterns in elite athletes: association with fatigue and infection.Br J Sports Med32: 25-
32, 1998.
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
21/31
20
19. Krzywkowski K, Petersen EW, Ostrowski K, Link-Amster H, Boza J,
Halkjaer-Kristensen J, and Pedersen BK. Effect of glutamine and protein
supplementation on exercise-induced decreases in salivary IgA.J Appl Physiol 91: 832-
838, 2001.
20. Lindberg K and Berglund B. Effect of treatment with nasal IgA on the
incidence of infectious disease in world-class canoeists.Int J Sports Med17: 235-238,
1996.
21. Mackinnon LT. Chronic exercise training effects on immune function.Med Sci
Sports Exerc 32: S369-S376, 2000.
22. Mackinnon LT, Ginn E, and Seymour GJ. Decreased salivary immunoglobulin
A secretion rate after intense interval exercise in elite kayakers.Eur J Appl Physiol 67:
180-184, 1993.
23. Mackinnon LT, Ginn EM, and Seymour GJ. Temporal relationship between
decreased salivary IgA and upper respiratory tract infection in elite athletes.Aust J Sci
Med Sport25: 94-99, 1993.
24. Mackinnon LT and Hooper SL. Mucosal (secretory) immune system responses
to exercise of varying intensity and during overtraining.Int J Sports Med15: S179-S183,
1994.
25. Mackinnon LT and Hooper SL. Plasma glutamine and upper respiratory tract
infection during intensified training in swimmers.Med Sci Sports Exerc 28: 285-290,
1996.
26. McNair DM, Lorr M, and Droppleman LF. Profile of Mood States Manual.
San Diego: Educational and Industrial Testing Service, 1971.
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
22/31
21
27. Morgan WP, Costill DL, Flynn MG, Raglin JS, and O'Connor PJ. Mood
disturbance following increased training in swimmers.Med Sci Sports Exerc 20: 408-
414, 1988.
28. Mouton C, Fillion L, Tawadros E, and Tessier R. Salivary IgA is a weak stress
marker.Behav Med15: 179-185, 1989.
29. Newsholme EA. Biochemical mechanisms to explain immunosuppression in
well-trained and overtrained athletes.Int J Sports Med15: S142-S147, 1994.
30. Nieman DC. Exercise immunology: nutritional countermeasures. Can J Appl
Physiol 26: S45-S55, 2001.
31. Parry-Billings M, Budgett R, Koutedakis Y, Blomstrand E, Brooks S,
Williams C, Calder PC, Pilling S, Baigrie R, and Newsholme EA. Plasma amino acid
concentrations in the overtraining syndrome: possible effects on the immune system.Med
Sci Sports Exerc 24: 1353-1358, 1992.
32. Proctor GB and Carpenter GH. Chewing stimulates secretion of human
salivary secretory immunoglobulin A.J Dent Res 80: 909-913, 2001.
33. Rowbottom DG, Keast D, Goodman C, and Morton AR. The haematological,
biochemical and immunological profile of athletes suffering from the overtraining
syndrome.Eur J Appl Physiol 70: 502-509, 1995.
34. Rowbottom DG, Keast D, and Morton AR. The emerging role of glutamine as
an indicator of exercise stress and overtraining. Sports Med21: 80-97, 1996.
35. Tharp GD and Barnes MW. Reduction of saliva immunoglobulin levels by
swim training.Eur J Appl Physiol 60: 61-64, 1990.
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
23/31
22
36. Tomasi TB, Trudeau FB, Czerwinski D, and Erredge S. Immune parameters in
athletes before and after strenuous exercise.J Clin Immunol 2: 173-178, 1982.
37. Verde TJ, Thomas SG, and Shephard RJ. Potential markers of heavy training
in highly trained distance runners.Br J Sports Med26: 167-175, 1992.
38. Wagenmakers AJM. Muscle amino acid metabolism at rest and during exercise:
role in human physiology and metabolism. In:Exercise and Sport Science Reviews,
edited by Holloszy J. Baltimore: Williams and Wilkins, 1998, p. 287-314.
39. Weltzin R, Traina-Dorge V, Soike K, Zhang JY, Mack P, Soman G, Drabik
G, and Monath TP. Intranasal monoclonal IgA antibody to respiratory syncytial virus
protects rhesus monkeys against upper and lower respiratory tract infections.J Infect Dis
174: 256-261, 1996.
40. Ziegler TR, Benfell K, Smith RJ, Young LS, Brown E, Ferrari-Baliviera E,
Lowe DK, and Wilmore DW. Safety and metabolic effects of L-glutamine
administration in humans.J Parent Enter Nutr14: 137S-146S, 1990.
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
24/31
23
Figure 1: Plasma glutamine concentration in glutamine (G) and placebo (P) groups over
time. Training and supplement duration are shown as solid and dashed lines,
respectively. Data represent means SEM, n = 6 per group, with the exception of T1 and
T2, where n = 7 in the P group. There was a significant effect of time (P < .05).
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
25/31
24
Figure 2: Salivary flow rate in chronic glutamine supplemented and placebo groups.
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
26/31
25
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
27/31
26
Figure 3: Salivary IgA concentration (A), concentration relative to protein (B), and output
(C) in chronic glutamine supplemented and placebo groups. * Significantly different from G
at T2 (P < .05). Significantly different from T1 and T3 (P < .05)
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
28/31
27
Figure 4: Salivary protein concentration in chronic glutamine supplemented and placebo
groups.
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
29/31
28
Figure 5: Nasal IgA relative to protein in chronic glutamine supplemented and placebo
groups. There was a significant effect of treatment (P < 0.05).
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
30/31
29
TABLE 1.Dietary intake
Glutamine Placebo P-value P-value
for treatment for time
Kilocalories (Record 1) 2262 174 2569 348
Kilocalories (Record 2) 2627 264 2688 327 0.62 0.21
Protein (g, Record 1) 80.2 8.6 111 11.4
Protein (g, Record 2) 97.0 14.2 104 8.1 0.16 0.60
Carbohydrates (g, Record 1) 297 19 314 38
Carbohydrates (g, Record 2) 345 33 322 51 0.95 0.32
Fat (g, Record 1) 88.2 11.2 101 17.9
Fat (g, Record 2) 93.5 11.0 106 15.2 0.51 0.47
Values are means SEM. Record 1 represents the food record for days 1-3 or 3-5.
Record 2 represents the food record for days 12-14.
-
7/29/2019 Chronic Glutamine Supplementation Increases Nasal but Not Salivary Iga During Nine Days of Interval Training
31/31
30
TABLE 2. POMS variables at each time point
T1 T2 T3 T4
Confusion 4.9 1.0 6.4 1.5 6.0 1.1 4.2 1.3
Tension 6.0 1.0 6.4 1.1 5.3 0.9 5.2 1.0
Depression 3.9 1.2 3.7 1.2 2.3 1.0 1.5 0.9
Anger 4.4 0.8 3.3 0.9 3.5 1.2 2.2 0.7
Vigor* 19.7 1.0a
16.8 1.4a,b
15.8 1.7b
18.4 1.9a,b
Fatigue* 6.1 0.6a
11.8 1.4b
10.8 1.5a,b
4.5 0.9a,c
Composite* 105.6 3.5a,b 114.8 5.2a 112.1 4.7a 99.1 5.0b
Group data are combined in this table. Values are means SEM. n = 13 for T1 and T2,
and n = 12 for T3 and T4. * Significant main effect of time (P < 0.05). Within each
variable, different letters are significantly different from each other as determined by
Sidakpost-hoc analysis.